CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 397 filers reported holding CRISPR THERAPEUTICS AG in Q4 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,272,873 | -43.9% | 31,313 | -9.8% | 0.08% | -49.7% |
| Q3 2022 | $2,269,000 | +7.5% | 34,727 | 0.0% | 0.16% | +17.9% |
| Q2 2022 | $2,110,000 | +11.6% | 34,727 | +15.3% | 0.14% | +47.4% |
| Q1 2022 | $1,890,000 | +4.2% | 30,113 | +25.8% | 0.10% | -10.4% |
| Q4 2021 | $1,814,000 | +23.4% | 23,933 | +82.3% | 0.11% | +24.7% |
| Q3 2021 | $1,470,000 | -33.5% | 13,129 | -3.9% | 0.08% | -38.8% |
| Q2 2021 | $2,211,000 | – | 13,655 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |